NEW!

Rabbit anti-ANKRD17 IHC Antibody Affinity Purified

bethyl
Bethyl Laboratories Catalog #
Validated
Target:
ANKRD17
Reactivity:
Human
Host:
Rabbit
Clonality:
Polyclonal
Format:
Whole IgG
Immunogen:
Between 1575 and 1625
Isotype:
IgG
Conjugate:
Unconjugated
Purity:
Antigen Affinity Purified
100 µl (50+ slides)

10 µl (5+ slides)

$131.00 $492.00
Qty:

Product Details

Specifications

Verified Reactivity
Human
Presumed Reactivity
Guinea Pig, Mouse, Dog, Pig, Bovine, Monkey
Antigen Species
Human
Concentration
250 µg/ml
Storage
2 - 8 °C
Shelf Life
1 year from date of receipt
Physical State
Liquid
Buffer
Tris-buffered Saline containing 0.1% BSA and 0.09% Sodium Azide
Request Formulation Change
Production Procedures
Antibody was affinity purified using an epitope specific to ANKRD17 immobilized on solid support.

The epitope recognized by IHC-00596 maps to a region between residue 1550 and 1600 of human ankyrin repeat domain 17 using the numbering given in entry NP_115593.3 (GeneID 26057).

Immunoglobulin concentration was determined using Beer’s Law where 1mg/mL IgG has an A280 of 1.4.
Antibody was affinity purified using an epitope specific to ANKRD17 immobilized on solid support.

The epitope recognized by IHC-00596-T maps to a region between residue 1550 and 1600 of human ankyrin repeat domain 17 using the numbering given in entry NP_115593.3 (GeneID 26057).

Immunoglobulin concentration was determined using Beer’s Law where 1mg/mL IgG has an A280 of 1.4.
Country of Origin
USA

Additional Product Information

ANKRD17 (ankyrin-repeat domain-containing protein 17) contains 25 ankyrin repeats and a K homology domain. It was originally identified as an antigen recognized by antibodies in the serum of breast cancer patients. Studies in mice show that this protein is involved in hepatic differentiation.

26057
ANKRD17
ankyrin repeat domain 17
O75179
Ankyrin repeat domain-containing protein 17

Alternate Names

ankyrin repeat domain-containing protein 17; gene trap ankyrin repeat protein; GTAR; MASK2; NY-BR-16; serologically defined breast cancer antigen NY-BR-16

Applications

Epitope exposure is recommended.

Epitope exposure with citrate buffer will enhancer staining.

Likely to work with frozen sections.

In some cases, the antibody may be diluted further than indicated.